This cannabis ETF has been a relatively better performer in a mixed market.
MSOS portfolio manager calls executive action a pivotal moment for cannabis policy
Curaleaf stock is up close to 90% in 2025 after President Donald Trump suggested marijuana reclassification could happen within weeks.
Should investors buy, sell, or hold CGC stock after its recent stock resurgence?
With federal marijuana reform gaining traction, the AdvisorShares Pure US Cannabis ETF (MSOS) has surged over 30% in 2025 and stands out as the top-performing fund to capture the sector’s breakout momentum....
When cannabis stocks exploded this week, Tilray Brands (TLRY) wasn’t just along for the ride - it could be setting up for meme stock status.
Cannabis stocks and ETFs soared on Monday after reports that U.S. President Donald Trump is considering reclassifying marijuana to a less restrictive drug category.The potential move would shift marijuana...
Wall Street was moderate in July, with SPDR S&P 500 ETF Trust SPY adding about 2.2%, SPDR Dow Jones Industrial Average ETF Trust DIA adding about 0.1% and the Nasdaq-100-heavy ETF Invesco QQQ Trust, Series...
U.S. stocks closed in the red on July 11, 2025. This drop came after President Donald Trump announced a 35% tariff on Canada and hinted at even higher duties globally, sparking renewed concerns over trade...
There's a lot of concern in the markets these days with how tariffs will affect growth stocks like Nvidia and Apple and whether they drag down their earnings.